| September 4, 2019 |
Psychiatric Drugs Aren’t
Barriers to Success in
Weight-Loss Program
Patients taking psychiatric drugs might be concerned that it will affect their weight loss, but that doesn’t appear to be the case with weight-management programs. Find out how the medications affected how many pounds were dropped in those taking psychiatric drugs versus those who were not. |
|
|
New Drugs Underused for Resistant Infection Despite Pharmacists’ Push
A survey of hospital pharmacists showed that they were strong proponents of using powerful new drugs to combat carbapenem-resistant Enterobacteriaceae. So why are the antibiotics underprescribed for the dangerous condition? Here is what researchers posited. |
|
AHA Issues New Scientific Advisory on Prescription
Omega-3 Fatty-Acid Benefits
Prescription omega-3 fatty acid medications effectively reduce extremely high triglyceride levels for most patients who require treatment, according to a new American Heart Association scientific statement. The authors advise against OTC products, however. Here is more information. |
|
|
Oral Steroid Type Doesn’t Appear to Matter in Childhood Croup
Winter is coming and so is croup. Usually, Infants and toddlers who have laryngotracheobronchitis are prescribed either prednisolone or low-dose dexamethasone. Responding to concerns that an evidence base for treatment was lacking, a new study has determined that the type of oral steroid doesn’t seem to make a difference. Find out more. |
|
|
Connect With U.S. Pharmacist
    |
